SRAMF (Sisram Medical) 5-Year Yield-on-Cost %: 5.81 (As of Jul. 09, 2026) — 25% Above Median


SRAMF Sisram Medical Ltd SRAMF
57 GF Score
Price $0.44
GF Value $0.98
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sisram Medical 5-Year Yield-on-Cost %?

Sisram Medical SRAMF 57 5-Year Yield-on-Cost % is 5.81 as of Jul. 09, 2026, which is 25% above its 10-year median of 4.64. GuruFocus rates SRAMF with a GF Score™ of 57/100 and a GF Value™ of $0.98 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 327 Medical Devices & Instruments companies, Sisram Medical ranks better than 86.85% on this metric.

Sisram Medical's yield on cost for the quarter that ended in Dec. 2025 was 5.81.


The historical rank and industry rank for Sisram Medical's 5-Year Yield-on-Cost % or its related term are showing as below:

SRAMF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.6   Med: 4.64   Max: 9.18
Current: 5.81


During the past 12 years, Sisram Medical's highest Yield on Cost was 9.18. The lowest was 0.60. And the median was 4.64.


SRAMF's 5-Year Yield-on-Cost % is ranked better than
86.85% of 327 companies
in the Medical Devices & Instruments industry
Industry Median: 2.39 vs SRAMF: 5.81

Sisram Medical  (OTCPK:SRAMF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Sisram Medical 5-Year Yield-on-Cost % Related Terms


SRAMF vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, Sisram Medical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sisram Medical 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sisram Medical's 5-Year Yield-on-Cost % falls into.


SRAMF
57GF Score
Sisram Medical Ltd SRAMF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sisram Medical 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sisram Medical is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 5.81 mean?
Sisram Medical (SRAMF) has a 5-Year Yield-on-Cost % of 5.81 as of Jul. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sisram Medical and its competitors. This is 25% above median its historical median of 4.64. Over the past decade, Sisram Medical's 5-Year Yield-on-Cost % has ranged from 0.60 to 9.18. According to the industry distribution chart, Sisram Medical ranks #43 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 13.1%.
Is Sisram Medical's 5-Year Yield-on-Cost % too high?
Sisram Medical's current 5-Year Yield-on-Cost % of 5.81 is 25% above median its 10-year median of 4.64. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 9.18. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.39. Sisram Medical's value of 5.81 is 143.1% above this industry median. Based on the distribution chart, Sisram Medical ranks #43 out of 327 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sisram Medical has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sisram Medical ranks #43 out of 327 companies for 5-Year Yield-on-Cost %. This places Sisram Medical in the top 13% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.39. Sisram Medical's value of 5.81 is 143.1% above this benchmark. Historically, Sisram Medical's own 5-Year Yield-on-Cost % has ranged from 0.60 to 9.18 over the past decade. While the company's 10-year median is 4.64 vs. the industry median of 2.39, Sisram Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.39, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sisram Medical's current 5-Year Yield-on-Cost % of 5.81 is 143.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sisram Medical and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sisram Medical's current 5-Year Yield-on-Cost % is 5.81, which is 25% above median its own 10-year median of 4.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.98, compared to a current price of $0.44 — trading 55.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 5.81, which is 25% above median its 10-year median of 4.64 and 143.1% above the Medical Devices & Instruments industry median of 2.39. Sisram Medical's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current 5-Year Yield-on-Cost % is 5.81 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sisram Medical (SRAMF) Overvalued in 2026?

Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued. The current stock price of $0.44 is trading 55.3% below its estimated GF Value™ of $0.98. GuruFocus considers Sisram Medical to be Significantly Undervalued.

Key valuation signals for SRAMF:

  • 5-Year Yield-on-Cost %: 5.81 (25% above median its 10-year median of 4.64)
  • GF Value™: $0.98 vs. price of $0.44 (55.3% below fair value)
  • GF Score™: 57/100 with 5 warning signs
  • Industry Position: 143.1% above the Medical Devices & Instruments median (#43 of 327)

No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sisram Medical Business Description

Other Exchanges 01696:Hong Kong
Address HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
57GF Score

Get the complete analysis for SRAMF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$0.98
GF Value